Flatiron Health’s Post

Hi, I hope this message finds you well. I am writing to share an exciting proposal with you - the establishment of *The Oncology Case Discussion Forum*, an upcoming platform designed exclusively for professionals dealing with oncology patients. The Oncology Case Discussion Forum aims to provide a collaborative space where oncologists can share challenging clinical cases, engage in evidence-based discussions, and access resources to enhance patient care and professional development. Before launching the forum, we would like to gather insights and feedback from esteemed professionals like yourself. Your input will be invaluable in shaping the platform to meet the needs and expectations of the oncology community. Key Objectives of the Survey: - Assess the need and interest in a collaborative case consultation forum among oncologists. - Understand the expectations and preferences regarding the features and functionality of the forum. - Identify potential challenges and concerns that need to be addressed before launching the platform. We invite you to participate in a brief survey to share your thoughts and insights on the Oncology Case Discussion Forum initiative. Your feedback will help us refine the platform and ensure its success. https://lnkd.in/dPS-892g Please find attached document outlining the proposal in more detail. Thank you in advance for your time and contribution. Together, we can create a valuable resource that will benefit the entire oncology community. Should you have any questions or require further information, please feel free to reach out to me directly. Best regards, Dr. Saba Karim

Value-based oncology care. A perspective via Blake Madden.

Great conversation with Jennifer Nelson @MDedge! Although there are countless additional metrics, here are 7 basic KPIs oncology practices should be tracking.

In this interview, Lalan Wilfong, M.D., shares insights from the Community Oncology Alliance’s 2024 Community Oncology Conference panel session titled "Defining Value in Oncology: Executing VBC Accurately & Ethically to Account for All Stakeholders." "Whenever we go into a value-based care arrangement, we want to make sure that the true heart of that is improving patient care and making sure that all of the payment models, quality metrics, and everything else goes toward improving that patient’s outcome and quality of life during the time we're under that model," said Dr Wilfong. Check out the full video here: https://lnkd.in/emqpV3wE #JournalOfClinicalPathways #ValueBasedCare #CancerCare #Oncology #EnhancingOncologyModel #COA2024

Advisory boards in oncology: How to get the best outcomes. See our new case study https://lnkd.in/gNC_czMp. From development through prelaunch and commercialization, advisory boards in oncology play a critical role in advancing the standards of care. The first and most important step is clear agreement on the objectives. The objectives determine the target profile for the participants and the ad board format. Although it’s great to talk with people we know it’s also great to include adversaries to obtain diverse perspectives. And premeeting interviews are important because they enrich the agenda.

The oncology care field is reaching another critical turning point, driven by rapidly advancing technologies, policy shifts, and aging populations. In the latest Q-Centrix blog post, Vice President, Oncology Market Lead, Karen Schmidt, draws on her extensive market knowledge to examine several urgent, strategic decisions facing oncology leaders today: https://bit.ly/4bhFUtr #OncologyData #CancerRegistry #ClinicalDataManagement

How are payers responding to the growth of competitive therapies in oncology? In this blog, MMIT’s Jory Fleischauer, Pharm.D. takes a look at the data on payer management approaches. Read now: https://ow.ly/gX1t50RlxVc #OncologyTherapies #CancerCare #PayerManagement #Oncology

Advisory boards in oncology: How to get the best outcomes. See our new case study https://lnkd.in/gNC_czMp. From development through prelaunch and commercialization, advisory boards in oncology play a critical role in advancing the standards of care. The first and most important step is clear agreement on the objectives. The objectives determine the target profile for the participants and the ad board format. Although it’s great to talk with people we know it’s also great to include adversaries to obtain diverse perspectives. And premeeting interviews are important because they enrich the agenda.

As Mr. Glenn Balasky says, “To stay ahead and manage revenue cycle well, it has to be treated as a priority. It’s not just a back office [issue to be] treated lightly. It’s probably the second most important thing that we do, after taking care of our patients.” Combining descriptive, predictive, and prescriptive analytics and disciplines processes (we believe) is the right approach to stay ahead!

In the latest issue of the Journal of Clinical Pathways, Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.   "This research offers promising evidence that effective pathways based on high-quality evidence and applied accurately to individual patient regimen decisions can lead to better adoption of on-pathway regimens and lower costs," said the authors.   Read the full report here 👉 https://lnkd.in/e9dESvMk   #JournalOfClinicalPathways #CancerCare #ValueBasedCare #ClinicalDecisionSupport #ValuePathways #DrugCostSavings